Results of General Meeting

Rex Bionics Plc

("Rex Bionics" or the "Company")

Results of General Meeting

01 August 2016: Rex Bionics plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, today announces all resolutions set out in the notice of the General Meeting, contained within the circular to shareholders dated 29 June 2016 (the "Circular") and the supplementary circular to shareholders dated 22 July 2016 (the "Supplementary Circular") were duly passed at its General Meeting held earlier today.

Accordingly, Initial Admission of the 3,600,000 Initial Subscription Shares is expected to take place at 8.00 a.m. on 02 August 2016. Following Admission, the total number of Ordinary Shares in the Company will be 21,430,526.

The Company does not hold any common shares in treasury and therefore this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.

A copy of this announcement has been posted on the Company's website at www.rexbionics.com/.

Capitalised terms in this announcement have the meanings given to them in the Circular and Supplementary Circular, except where the context requires otherwise.

For further information please contact:

Rex Bionics Plc

Crispin Simon, Chief Executive Officer

+44 (0) 781 086 6386

Peter Worrall, Chief Financial Officer

+44 (0)1428 645416

Stifel Nicolaus Europe Limited (NOMAD and Broker)

Jonathan Senior/ Stewart Wallace / Ben Maddison

+44 (0) 20 7710 7600

Consilium Strategic Communications

Mary-Jane Elliott / Chris Welsh

[email protected]

+44 (0) 203 709 5700